Key Insights

Highlights

Success Rate

79% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

7.3%

3 terminated out of 41 trials

Success Rate

78.6%

-7.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

45%

5 of 11 completed with results

Key Signals

5 with results79% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (9)
P 1 (4)
P 2 (8)

Trial Status

Recruiting12
Completed11
Not Yet Recruiting5
Active Not Recruiting4
Terminated3
Withdrawn3

Trial Success Rate

78.6%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (41)

Showing 20 of 20 trials
NCT07446777Not ApplicableRecruiting

FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease

NCT02726750RecruitingPrimary

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

NCT06383143Recruiting

Promoting Diagnosis and Management of AL in Italy (ProDigALIty)

NCT05640843Not ApplicableRecruitingPrimary

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

NCT05136807RecruitingPrimary

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

NCT05361694Recruiting

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

NCT06472830Enrolling By InvitationPrimary

MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study

NCT01408225Recruiting

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

NCT05969821Not Yet Recruiting

Clonal Hematopoiesis of Immunological Significance

NCT04850846Phase 2Active Not RecruitingPrimary

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

NCT01237054Phase 2Completed

Imaging in MGUS, SMM and MM

NCT07305662Not ApplicableNot Yet RecruitingPrimary

Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study

NCT06055894Not ApplicableRecruiting

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

NCT04114084Recruiting

Sleep Apnea in Patients With MGUS and MM

NCT06046287Phase 2Withdrawn

Daratumumab for Polyneuropathy Associated With MGUS

NCT03327597Not ApplicableActive Not RecruitingPrimary

Iceland Screens, Treats or Prevents Multiple Myeloma

NCT04920084Not ApplicableActive Not RecruitingPrimary

A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

NCT05831358Not ApplicableActive Not Recruiting

Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program

NCT06559033Not Yet RecruitingPrimary

Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS

NCT06895291Recruiting

Whole Body MRI in Oncology

Scroll to load more

Research Network

Activity Timeline